droxidopa has been researched along with Pain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harima, A; Takagi, H | 1 |
| Inoue, K; Kunimoto, M; Ohshima, F | 1 |
1 review(s) available for droxidopa and Pain
| Article | Year |
|---|---|
[Pain caused by ephaptic transmission occurring in the recovery phase of diabetic vascular mononeuropathy was effectively suppressed with L-threo-3,4-dihydroxyphenyl-serine].
Topics: Adrenergic alpha-Agonists; Baroreflex; Diabetic Neuropathies; Droxidopa; Humans; Leg; Male; Middle Aged; Midodrine; Muscle, Skeletal; Nociceptors; Pain; Sympathetic Nervous System; Synaptic Transmission; Vasoconstrictor Agents | 1998 |
1 trial(s) available for droxidopa and Pain
| Article | Year |
|---|---|
Analgesic effect of L-threo-3,4-dihydroxyphenylserine (L-DOPS) in patients with chronic pain.
Topics: Administration, Oral; Adult; Aged; Droxidopa; Female; Humans; Male; Middle Aged; Pain; Time Factors | 1996 |